Reuters AlertNet Full site
Homepage | Newsdesk | NGO Latest | Crisis briefings | Country profiles | MediaWatch | Jobs | Alerting | Login

NEWSDESK

WHO likely to give H1N1 jab guidance on Monday
10 Jul 2009 12:41:30 GMT
Source: Reuters
* WHO expert set to give briefing on flu vaccine Monday

* H1N1-resistant cases have raised interest in jab

(updates with WHO spokeswoman saying briefing likely on Monday)

GENEVA, July 10 (Reuters) - The World Health Organisation (WHO) will probably hold a media briefing on Monday to issue guidance about the need for a H1N1 influenza jab, a WHO spokeswoman said on Friday.

"The recommendations are still in the process of being developed," Fadela Chaib told a news briefing in Geneva, where the United Nations agency is based.

"The press conference will probably be on Monday," she later told Reuters.

Marie-Paule Kieny, WHO director of the Initiative for Vaccine Research, would give a news briefing once the recommendations emerging from the closed-door WHO meeting on Tuesday are approved by WHO Director-General Margaret Chan.

The WHO raised its influenza pandemic alert to the highest level on June 11 in response to the worldwide spread of H1N1, a newly discovered virus strain commonly known as swine flu.

Vaccine makers such as Sanofi-Aventis <SASY.PA>, Novartis <NOVN.VX>, Baxter <BAX.N>, GlaxoSmithKline <GSK.L> and Solvay <SOLB.BR> are seeking WHO guidance about whether to ramp up production of jabs for the strain, to keep making seasonal flu vaccines, or to produce a combination.

The discovery of three isolated cases of H1N1 flu in Denmark, Japan and Hong Kong that resisted treatment with the anti-viral drug Tamiflu, made by Roche <ROG.VX> and Gilead <GILD.O>, has raised interest in a jab to prevent infection.

The WHO said earlier this week that Tamiflu-resistant H1N1 flu does not appear to be spreading in a sustained or worrisome way. All patients with the resistant variety have recovered fully, and their viruses were sensitive to treatment with the other anti-viral recommended by the WHO, the inhaled drug Relenza made by Glaxo under license from Biota <BTA.AX>. (Reporting by Laura MacInnis and Stephanie Nebehay; Editing by Louise Ireland)


AlertNet news is provided by

Email this article       Send comments

Topics

•  Health

MORE >>

Emergencies

•  Swine flu

MORE >>

NGO latest

•  Time to show your climate credibility, G8 leaders urged
Christian Aid - UK

•  The fight against Chagas: Time to focus on patients
MSF International

•  Phone interview with Robert Przedpelski, camp manager at Swabi camp, Pakistan, Saturday 4 July 2009
Red Cross - UK

•  Deadly Cold Wave Brings Misery to Southern Peru
ADRA - International

•  Distribution of 1.2Million servings of soup begins in Paarl East
WER - UK

MORE >>

Latest news

•  WHO likely to give H1N1 jab guidance on Monday

•  TEXT-G8 Summit statement on food security

•  INTERVIEW-Regional meeting won't be disrupted - Thai minister

•  G8 discusses blocking oil market speculation-Italy

•  G8 pledges $20 bln in farm aid to poor nations

MORE >>
AlertNet news is provided by

Del.icio.us Del.icio.us  |   Digg Digg  |   NewsVine NewsVine  |   Reddit Reddit   
Thumb for /thefacts/imagerepository/RTRPICT/2009-07-09T232252Z_01_CD06_RTRIDSP_2_EL-SALVADOR_mainimage.jpg|/thenews/pictures/CD06.htm
Thumb for /thefacts/imagerepository/RTRPICT/2009-07-09T232009Z_01_CD05_RTRIDSP_2_EL-SALVADOR_mainimage.jpg|/thenews/pictures/CD05.htm
Thumb for /thefacts/imagerepository/RTRPICT/2009-07-09T231800Z_01_CD04_RTRIDSP_2_EL-SALVADOR_mainimage.jpg|/thenews/pictures/CD04.htm
Thumb for /thefacts/imagerepository/RTRPICT/2009-07-09T230508Z_01_CD03_RTRIDSP_2_EL-SALVADOR_mainimage.jpg|/thenews/pictures/CD03.htm
Thumb for /thefacts/imagerepository/RTRPICT/2009-07-08T014102Z_01_BAS19_RTRIDSP_2_SOCCER-LATAM-LIBERTADORES-FLU_mainimage.jpg|/thenews/pictures/BAS19.htm

Five-year old Joel Ramirez (L) wears a surgical mask as a precaution against the influenza A H1N1 virus while he sits with his family at the waiting room at the Benjamin ...



Disclaimers |  Copyright |  Privacy |  Contact Us |  Feedback |  About Us |  RSS XML

Last updated:Fri Jul 10 12:44:23 2009